The Pathway to Biomarker Discovery: Carbonic Anhydrase IX and the Prediction of Immune Responsiveness
- 15 May 2005
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 11 (10) , 3601-3603
- https://doi.org/10.1158/1078-0432.ccr-05-0475
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Carbonic Anhydrase IX Expression Predicts Outcome of Interleukin 2 Therapy for Renal CancerClinical Cancer Research, 2005
- Ontogeny and Oncogenesis Balance the Transcriptional Profile of Renal Cell CancerCancer Research, 2004
- Quiescent phenotype of tumor-specific CD8+ T cells following immunizationBlood, 2004
- Update on the Role of Interleukin 2 and Other Cytokines in the Treatment of Patients with Stage IV Renal CarcinomaClinical Cancer Research, 2004
- A Genomic- and Proteomic-Based Hypothesis on the Eclectic Effects of Systemic Interleukin-2 Administration in the Context of Melanoma-Specific ImmunizationCells Tissues Organs, 2004
- Strict regulation of CAIXG250/MN by HIF-1α in clear cell renal cell carcinomaOncogene, 2004
- Interleukin 2 receptor antagonists for kidney transplant recipientsPublished by Wiley ,2004
- Active-specific immunization against melanoma: Is the problem at the receiving end?Seminars in Cancer Biology, 2003
- Imiquimod: modes of actionBritish Journal of Dermatology, 2003
- Functional Association of Nmi with Stat5 and Stat1 in IL-2- and IFN γ-Mediated SignalingPublished by Elsevier ,1999